Insider · CIK 0001474632

ALBAN CARLOS

Reports to the SEC for 4 companies · EAGAN, MN

sec.gov

Transactions

Companies

Filings

CIK

0001474632

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	SOLVSolventum Corp · Restricted Stock UnitsA Award	Director	AAward	+3,300 sh	—	—	3,300
2026-04-30	SOLVSolventum Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,403 sh	—	—	0
2026-04-30	SOLVSolventum CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,403 sh	—	—	8,947
2026-03-27	SOLVSolventum Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,980 sh	—	—	0
2026-03-27	SOLVSolventum CorpM Exercise/Conversion	Director	MExercise/Conversion	+1,980 sh	—	—	5,544
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−28.9K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30.2K sh	—	—	0
2025-05-14	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	28,861
2025-05-13	SOLVSolventum CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,564 sh	—	—	3,564
2025-05-13	SOLVSolventum Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,564 sh	—	—	0
2025-04-30	SOLVSolventum Corp · Restricted Stock UnitsA Award	Director	AAward	+3,403 sh	—	—	3,403
2024-05-16	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,095 sh	—	—	18,801
2024-05-16	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,216
2024-05-13	SOLVSolventum Corp · Restricted Stock UnitsA Award	Director	AAward	+3,564 sh	—	—	3,564
2024-05-13	SOLVSolventum Corp · Restricted Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	5,544
2023-05-24	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,774
2023-05-24	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,648 sh	—	—	14,706
2022-07-14	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	10,058
2022-07-14	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30.2K sh	—	—	30,160
2020-11-16	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−116K sh	$100.00	−$11.6M	114,899
2020-11-16	ABBVAbbVie Inc.M Exercise/Conversion	Vice Chairman	MExercise/Conversion	+116K sh	$35.88	+$4.16M	230,729
2020-11-16	ABBVAbbVie Inc. · Option(Right to buy)M Exercise/Conversion	Vice Chairman	MExercise/Conversion	−116K sh	—	—	0
2020-07-07	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−23K sh	$100.00	−$2.3M	114,899
2020-07-07	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−30.3K sh	$100.00	−$3.03M	137,899
2020-02-28	ABBVAbbVie Inc.F Tax Payment	Vice Chairman	FTax Payment	−32.1K sh	$85.42	−$2.74M	168,224
2020-02-20	ABBVAbbVie Inc. · Option (right to buy)A Award	Vice Chairman	AAward	+115K sh	—	—	114,566
2020-02-20	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+10.1K sh	—	—	200,316
2020-02-20	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+8,214 sh	—	—	190,191
2020-02-20	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+14.3K sh	—	—	181,977
2020-02-20	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+39.8K sh	—	—	167,637
2019-02-28	ABBVAbbVie Inc.F Tax Payment	Vice Chairman	FTax Payment	−24.1K sh	$79.41	−$1.92M	127,877
2019-02-21	ABBVAbbVie Inc. · Option (right to buy)A Award	Vice Chairman	AAward	+62.3K sh	—	—	62,305
2019-02-21	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+8,215 sh	—	—	152,002
2019-02-21	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+14.3K sh	—	—	143,787
2019-02-21	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+13.4K sh	—	—	129,447
2019-02-21	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+18.5K sh	—	—	116,097
2018-03-01	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−14.8K sh	$114.43	−$1.7M	97,552
2018-03-01	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−47K sh	$114.63	−$5.39M	112,381
2018-03-01	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−19.2K sh	$113.75	−$2.18M	159,378
2018-03-01	ABBVAbbVie Inc.M Exercise/Conversion	Vice Chairman	MExercise/Conversion	+48.1K sh	$29.23	+$1.41M	178,547
2018-03-01	ABBVAbbVie Inc. · Option (right to buy)M Exercise/Conversion	Vice Chairman	MExercise/Conversion	−48.1K sh	—	—	0
2018-02-28	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−2,579 sh	$117.85	−$304K	130,447
2018-02-28	ABBVAbbVie Inc.F Tax Payment	Vice Chairman	FTax Payment	−26K sh	$118.26	−$3.07M	133,026
2018-02-15	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+14.3K sh	—	—	159,002
2018-02-15	ABBVAbbVie Inc. · Option (right to buy)A Award	Vice Chairman	AAward	+44.4K sh	—	—	44,430
2018-02-15	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+16.6K sh	—	—	144,662
2018-02-15	ABBVAbbVie Inc.A Award	Vice Chairman	AAward	+13.4K sh	—	—	128,950
2017-06-14	ABBVAbbVie Inc.S Sale	Vice Chairman	SSale	−45.8K sh	$70.00	−$3.21M	114,745

Recent filings

Accepted (ET)
May 184
ALBAN CARLOS0001474632-26-000008
SEC(opens sec.gov)
May 14
ALBAN CARLOS0001474632-26-000005
SEC(opens sec.gov)
Mar 304
ALBAN CARLOS0001474632-26-000003
SEC(opens sec.gov)
Jul 24
ALBAN CARLOS0001104659-25-065303
SEC(opens sec.gov)
May 154
ALBAN CARLOS0001628280-25-025960
SEC(opens sec.gov)
May 154
ALBAN CARLOS0001104659-25-049656
SEC(opens sec.gov)
May 24
ALBAN CARLOS0001628280-25-021889
SEC(opens sec.gov)
May 174
ALBAN CARLOS0001104659-24-062975
SEC(opens sec.gov)
May 154
ALBAN CARLOS0001127602-24-015492
SEC(opens sec.gov)
May 254
ALBAN CARLOS0001104659-23-064644
SEC(opens sec.gov)
Jul 154
ALBAN CARLOS0001104659-22-079983
SEC(opens sec.gov)

Companies

Address

1750 YANKEE DOODLE ROAD

EAGAN, MN, 55121